2025-01-29 03:57:00 :
On January 28th (Reuters) -s Stryker defeated Wall Street to estimate the profit in the fourth quarter and the prediction of 2025 revenue is much higher than Tuesday’s expectations. This is the medical and surgery equipment for medical care and surgery Promoting strong demand.
With the more and more elderly people in the United States, more and more people choose to take surgical therapy, medical and surgical equipment manufacturers are gradually increasing demand. The delayed elective surgery during popularity.
According to the data assembled by LSEG, Stryker predicts that the profit per share in 2025 is between 2025, which is between US $ 13.45 and $ 13.70, which exceeds the average estimation value of analysts 13.51 US dollars.
In addition, medical equipment manufacturers have announced that they will sell their spine implant business to private investment companies Viscogliosi Brothers to form a separate company VB Spine.
The transaction is expected to be completed in the first half of 2025.
The company also disclosed the new chief financial officer. Preston Wells, the financial leader of the Orthopedic Department, will replace the current Glenn Boehnlein on April 1.
STRYKER’s sales of medical surgery and neural technology departments increased by 10.6 % to US $ 3.89 billion. In their orthopedic segmentation, they increased by 10.8 % to $ 2.55 billion.
Earlier this month, the company headquartered in Michigan signed a $ 4.9 billion transaction to purchase Inari Medical to expand its product portfolio to treat vascular disease.
Three months as of December 31, Strick’s total revenue was US $ 6.44 billion, which was higher than the analyst’s expectations of US $ 6.36 billion.
After the adjustment, the company’s income per share is $ 4.01, which is estimated to be $ 3.87.
The company’s stocks fell 1.6 % to $ 389 in extended transactions. (Report by Mariam Sunny in Bangalore; editor of Sriraj Kalluvila and Shilpi Majumdar)
Follow us On Social Media   Twitter/X
